Abstract
Superoxide is involved in a plethora of pathological and physiological processes via oxidative stress and/or signal transduction pathways. Superoxide dismutase (SOD) mimics have, thus, been actively sought for clinical and mechanistic purposes. Manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin (MnTBAP) is one of the most intensely explored “SOD mimics” in biology and medicine. However, we show here that this claimed SOD activity of MnTBAP in aqueous media is not corroborated by comprehensive structure–activity relationship studies for a wide set of Mn porphyrins and that MnTBAP from usual commercial sources contains different amounts of noninnocent trace impurities (Mn clusters), which inhibited xanthine oxidase and had SOD activity in their own right. In addition, the preparation and thorough characterization of a high-purity MnTBAP is presented for the first time and confirmed that pure MnTBAP has no SOD activity in aqueous medium. These findings call for an assessment of the relevance and suitability of using MnTBAP (or its impurities) as a mechanistic probe and antioxidant therapeutic; conclusions on the physiological and pathological role of superoxide derived from studies using MnTBAP of uncertain purity should be examined judiciously. An unequivocal distinction between the biological effects due to MnTBAP and that of its impurities can only be unambiguously made if a pure sample is/was used. This work also illustrates the contribution of fundamental structure–activity relationship studies not only for drug design and optimization, but also as a “watchdog” mechanism for checking/spotting eventual incongruence of drug activity in chemical and biological settings.
Similar content being viewed by others
Notes
At pH 7.8 the carboxylato groups of MnTBAP are deprotonated and the resulting species bears an overall −3 or −4 charge depending on the oxidation state of the Mn: [MnIIITBAP]3− (six negative charges on the ring and three positive charges on the MnIII center) or [MnIITBAP]4− (six negative charges on the ring and two positive charges on the MnII center).
Abbreviations
- DMF:
-
N,N-Dimethylformamide
- EDTA:
-
Sodium salt of ethylenediaminetetraacetic acid
- ESI:
-
Electrospray ionization
- Fc:
-
Ferrocene
- H2TBAP:
-
5,10,15,20-Tetrakis(4-benzoic acid)porphyrin
- H2TBAP-TME:
-
5,10,15,20-Tetrakis(4-benzoic acid)porphyrin tetramethyl ester
- IC20 :
-
Concentration that causes 20% inhibition of xanthine oxidase activity
- MnTBAP:
-
Manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin
- Mn(TBAP-TME)Cl:
-
Manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin tetramethyl ester chloride
- MnTE-2-PyP5+ :
-
Manganese(III) 5,10,15,20-tetrakis(N-ethylpyridinium-2-yl)porphyrin
- MnTnHex-2-PyP5+ :
-
Manganese(III) 5,10,15,20-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin
- MS:
-
Mass spectrometry
- MS/MS:
-
Tandem mass spectrometry
- NHE:
-
Normal hydrogen electrode
- NMR:
-
Nuclear magnetic resonance
- RNS:
-
Reactive nitrogen species
- ROS:
-
Reactive oxygen species
- SAR:
-
Structure–activity relationship
- SOD:
-
Superoxide dismutase
- X:
-
Xanthine
- XO:
-
Xanthine oxidase
References
Salvemini D, Riley DP, Cuzzocrea S (2002) Nat Rev Drug Discov 1:367–374
Szabó C, Ischiropoulos H, Radi R. (2007) Nat Rev Drug Discov 6:662–680
Salvemini D, Cuzzocrea S (2003) Crit Care Med 31:S29–S38
Pervaiz S, Clement MV (2007) Int J Biochem Cell Biol 39:1297–1304
Culotta VC, Yang M, O’Halloran TV (2006) Biochim Biophys Acta Mol Cell Res 1763:747–758
Spasojević I, Chen Y, Noel TJ, Yu Y, Cole MP, Zhang L, Zhao Y, St Clair DK, Batinić-Haberle I (2007) Free Radic Biol Med 42:1193–1200
Batinić-Haberle I, Spasojević I, Stevens RD, Bondurant B, Okado-Matsumoto A, Fridovich I, Vujasković Z, Dewhirst MW (2006) Dalton Trans 617–624
Spasojević I, Batinić-Haberle I, Rebouças JS, Idemori YM, Fridovich I (2003) J Biol Chem 278:6831–6837
Spasojević I, Batinić-Haberle I (2001) Inorg Chim Acta 317:230–242
Batinić-Haberle I, Benov L, Spasojević I, Hambright P, Crumbliss AL, Fridovich I (1999) Inorg Chem 38:4011–4022
Saba H, Batinić-Haberle I, Munusamy S, Mitchell T, Lichti C, Megyesi J, MacMillan-Crow LA (2007) Free Radic Biol Med 42:1571–1578
Wood PM (1988) Biochem J 253:287–289
Sawyer DT, Valentine JS (1981) Acc Chem Res 14:393–400
Vance CK, Miller AF (1998) J Am Chem Soc 120:461–467
Ellerby RM, Cabelli DE, Graden JA, Valentine JS (1996) J Am Chem Soc 118:6556–6561
Goldstein S, Fridovich I, Czapski G (2006) Free Radic Biol Med 41:937–941
Zhao Y, Chaiswing L, Oberley TD, Batinić-Haberle I, St Clair W, Epstein CJ, St Clair D (2005) Cancer Res 65:1401–1405
Waud WR, Brady FO, Wiley RD, Rajagopalan KV (1975) Arch Biochem Biophys 169:695–701
Gritzner G, Kůta J (1984) Pure Appl Chem 56:461–466
Gagné RR, Koval CA, Lisensky GC (1980) Inorg Chem 19:2854–2855
Johnstone RAW, Nunes MLPG, Pereira MM, Gonsalves, AMd’AR, Serra AC (1996) Heterocycles 43:1423–1437
Lindsey JS, Schereiman IC, Hsu HC, Kearney PC, Marguerettaz AM (1987) J Org Chem 52:827–836
do Nascimento E, Silva GdeF, Caetano FA, Fernandes MAM, da Silva DC, de Carvalho MEMD, Pernaut JM, Rebouças JS, Idemori YM (2005) J Inorg Biochem 99:1193–1204
Lahaye D, Muthukumaran K, Hung C-H, Gryko D, Rebouças JS, Spasojević I, Batinić-Haberle I, Lindsey JS (2007) Bioorg Med Chem 15:7066–7086
Hambright P (1989) Inorg Chim Acta 157:95–98
Spasojević I, Batinić-Haberle I, Stevens RD, Hambright P, Thorpe AN, Grodkowski J, Neta P, Fridovich I (2001) Inorg Chem 40:726–739 (and references therein)
Riley DP (1999) Chem Rev 99:2573–2587
Pasternack RF, Huber PR, Boyd P, Engasser G, Francesconi L, Gibbs E, Fasella P, Venturo GC, Hinds LdeC (1972) J Am Chem Soc 94:4511–4517
Buchler JW, Kokisch W, Smith PD (1978) Struct Bonding 34:79–134 (and references therein)
Archibald FS, Fridovich I (1982) Arch Biochem Biophys 214:452–463
Dismukes GC (1996) Chem Rev 96:2909–2926
Evangelisti M, Bartolomé J (2000) J Magn Magn Mater 221:99–102
Bommer JC, Hambright P (2002) In: Smith AG, Witty M (eds) Heme, chlorophyll, and bilins: methods and protocols. Humana, Totowa, pp 39–67
Rebouças JS, de Carvalho MEMD, Idemori YM (2002) J Porphyrins Phthalocyanines 6:50–55
Kadish KM, Han BC, Franzen MM, Araullo-McAdams C (1990) J Am Chem Soc 112:8364–8368
Day BJ, Shawen S, Liochev SI, Crapo JD (1995) J Pharmacol Exp Ther 275:1227–1232
Ferrer-Sueta G, Vitturi D, Batinić-Haberle I, Fridovich I, Goldstein S, Czapski G, Radi R (2003) J Biol Chem 278:27432–27438
Lee J, Hunt JA, Groves JT (1998) J Am Chem Soc 120:6053–6061
Coulter AD, Emerson JP, Kurtz DM, Cabelli DE (2006) J Am Chem Soc 122:11555–11556
Ferrer-Sueta G, Hanninbal L, Batinić-Haberle I, Radi R (2006) Free Radic Biol Med 41:503–512
Batinić-Haberle I, Spasojević I, Stevens RD, Hambright P, Neta P, Okado-Matsumoto A, Fridovich I (2004) J Chem Soc Dalton Trans 1696–1702
Al-Mahrebi M, Fridovich I, Benov L (2002) Arch Biochem Biophys 402:104–109
Sanchez RJ, Srinivasan C, Munroe WH, Wallace MA, Martins J, Kao TY, Le K, Gralla EB, Valentine JS (2005) J Biol Inorg Chem 10:913–923
Lin Y-T, Hoang H, Hsieh SI, Rangel N, Foster AL, Sampayo JN, Lithgow GJ, Srinivasan C (2006) Free Radic Biol Med 40:1185–1193
Culotta VC, Yang M, Hall MD (2005) Eukaryot Cell 4:1159–1165
Korsvik C, Patil S, Seal S, Self WT (2007) Chem Commun 1056–1058 (and references therein)
Goldstein S, Czapski G, Heller A (2005) Free Radic Biol Med 38:839–845
Hansch C, Leo A, Taft RW (1991) Chem Rev 91:165–195
Andrieux CP, Hapiot P, Savéant J-M (1987) J Am Chem Soc 109:3768–3775
Che Y, Tsushima M, Matsumoto F, Okajima T, Tokuda K, Ohsaka T (1996) J Phys Chem 100:20134–20137
Ashur I, Brandis A, Greenwald M, Vakrat-Haglili Y, Rosenbach-Belkin V, Scheer H, Scherz A (2003) J Am Chem Soc 125:8852–8861
Tauskela JS, Brunette E, Kiedrowski L, Lortie K, Hewitt M, Morley P (2006) J Neurochem 98:1234–1342
Tauskela JS, Brunette E, O’Reilly N, Mealing G, Comas T, Gendron TF, Monette R, Morley P (2005) FASEB J 19:1734–1736
Konorev EA, Kotamraju S, Zhao H, Shasi H, Kalivendi S, Joseph J, Kalyanaraman B (2002) Free Radic Biol Med 33:988–987
Groves JT (1999) Curr Opin Chem Biol 226
Munroe W, Kingsley C, Durazo A, Gralla EB, Imlay JA, Srinivasan C, Valentine JS (2007) J Inorg Biochem 101:1875–1882
Shirazi A, Goff HM (1982) J Am Chem Soc 104:6318–6322
VanAtta RB, Strouse CE, Hanson LK, Valentine JS (1987) J Am Chem Soc 109:1425–1434
Sisemore MF, Selke M, Burstyn JN, Valentine JS (1997) Inorg Chem 36:979–984
Zhao Y, Chaiswing L, Oberley T D, Batinić-Haberle I, St. Clair W, Epstein CJ, St. Clair D (2005) Cancer Res 65:1401–1405
Moeller BJ, Batinić-Haberle I, Spasojevic I, Rabbani ZN, Anscher MS, Vujasković Z, Dewhirst MW (2005) Int J Rad Oncol Biol Phys 63:545–552
Tse H, Milton MJ, Piganelli JD (2004) Free Radic Biol Med 36:233–247
Acknowledgements
The authors are grateful for the valuable discussions with Irwin Fridovich and Peter Hambright. This work was supported by the National Institutes of Health grants NIH IR21-ESO/3682, U19A167798-01, and NIH/NCI DCCC Core Grant 5-P30-CA14236-29.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rebouças, J.S., Spasojević, I. & Batinić-Haberle, I. Pure manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin (MnTBAP) is not a superoxide dismutase mimic in aqueous systems: a case of structure–activity relationship as a watchdog mechanism in experimental therapeutics and biology. J Biol Inorg Chem 13, 289–302 (2008). https://doi.org/10.1007/s00775-007-0324-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-007-0324-9